The retatrutide triple agonist GLP-1 GIP glucagon mechanism works through three parallel axes: GLP-1 receptor activation: Stimulates glucose-dependent insulin secretion from pancreatic beta cells, suppresses glucagon release from alpha cells, slows gastric emptying, and reduces appetite signalling in the hypothalamus
Final Thoughts and Call to Action Peptide therapy offers a safe, medically backed, and highly personalized approach to healing, anti-aging, and performance optimization
Your provider should check your weight, blood sugar (if relevant), and side effect profile at regular intervals after the switch to optimize your dose and ensure the transition is successful
We also discuss strength and endurance training, assessing risk and how Alex prepares mentally and physically for extreme challenges
9(2): 15361 Moore RD, Wong WM, Keruly JC, et al